Assistant Professor, Medicine, University of Maryland School of Medicine
Endocrinology
Dr. Richard B. Horenstein, MD
|
|
Give Review
Richard B. Horenstein, MD is an expert in the field of Endocrinology. He attended Jefferson Medical College. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Richard Horenstein has written publications. He has 27 publications published with PubMed. The lastest publication is: 'Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogr...' He accepts all Medicare patients.
Publications
- Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogr...
- Null mutation in hormone-sensitive lipase gene and risk of type 2 Diabetes.
- Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.
- The CYP2C19*17 variant is not independently associated With clopidogrel response.
- Pharmacogenomics of anti-platelet and anti-coagulation therapy.
- Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics.
- Genetic Variation in PEAR1 is Associated With Platelet Aggregation and Cardiovascular Outcomes.
- The ABCG8 G574R Variant, Serum Plant Sterol Levels, and Cardiovascular Disease Risk in the Old Order Amish.
- The functional G143E variant of carboxylesterase 1 is associated With increased clopidogrel active metabolite levels and greater clopidogrel response.
- Analysis of the gut microbiota in the old order amish and its relation to the metabolic syndrome.
- A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma.
- Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.
- Association of cytochrome P450 2C19 genoType with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
- A null mutation in human APOC3 confers a favorable plasma Lipid profile and apparent cardioprotection.
- The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and PhenoType Intervention (HAPI) Heart Study.
- Acute-phase serum amyloid A: an inflammatory adipokine and potential link between Obesity and its metabolic complications.
- Does bariatric surgery reduce Obesity-related comorbidities?
- Genetics of Diabetes.
- Adrenal cortical adenoma With excess black pigment deposition, combined With myelolipoma and clinical Cushing's syndrome.
- Cholesterol predicts stroke mortality in the Women's Pooling Project.
- Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.
- Paraoxonase 1 (PON1) gene variants are not associated With clopidogrel response.
- Circulating CD34+ Cell Count is Associated With Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk.
- Two cases of Thyroid storm-associated cholestatic jaundice.
- Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability.
- OxyLipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.
Schools
Thomas Jefferson University
University Mich Health Sys
University MD Med Sys
Conditions Treated
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- Diabetes Mellitus, Secondary
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Maryland -
University of Michigan Hospitals and Health Centers -
Jefferson Medical College
Hospital
-
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1902852080 | |
| NPPES Provider LastName | HORENSTEIN | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 121.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902852080 |
| Last Name Of The Provider | HORENSTEIN |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Fredric E. Wondisford, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Adrian Dobs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rana Malek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley B. Davidson, MD |
|
|
Dr. Alan R. Shuldiner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Ann E. Fraker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aldo T. Paz-Guevara, MD |
|
|
Dr. Deepti Bahl, MD
This Doctor is OpenDoctor Recommended.
|